DGAP-News: MediClin AG / Key word(s): 9-month figures MediClin AG: In the first nine month of FY 2016 Group sales increase by EUR 20.8 mill. or 5.0 % up to EUR 435.2 mill. against previous years' figure 10.11.2016 / 14:33 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MEDICLIN: In the first nine month of FY 2016 Group sales increase by EUR 20.8 mill. or 5.0 % up to EUR 435.2 mill. against previous years' figure Offenburg, 10 November, 2016 - In the first nine months of FY 2016, MEDICLIN achieved Group sales of EUR 435.2 mill. (9M 2015: EUR 414.4 mill.) thus being up EUR 20.8 mill. or 5.0 % compared with the first nine months of 2015. The occupancy rate was 88.4 % (9M 2015: 87.7 %). The Group operating result improved by EUR 0.4 mill. from EUR 17.4 mill. to EUR 17.8 mill. Sales increase in the post-acute and acute segment and in the business area nursing care In the post-acute segment sales amounted to EUR 262.9 mill and were EUR 15.3 mill.or 6.2 % higher than in the same period of the previous year. This growth was driven by the good utilisation of capacities in neurology, acute neurology, psychosomatics, orthopaedics and geriatrics. The post- acute segment result improved from EUR 15.8 mill. up to 18.8 mill. The segment-EBIT-margin was 7.2 % (9M 2015: 6.4 %). In the acute segment sales increased by EUR 4.7 mill or 3.1 % up to EUR 158.3 mill. Sales of the second and third quarter of 2016 were significantly above the comparable previous year's quarters. Higher expenses led to a decrease of the segment result from EUR 7.2 mill. to EUR 5.2 mill. The segment-EBIT-margin declined from 4.7 % to 3.3 %. Sales in the nursing care business area increased by EUR 0.5 mill. up to EUR 10.9 mill. on the back of an improvement of the occupancy rate (9M 2016: 96.2 %; 9M 2015: 95.6 %). In the first nine months of 2016, EUR 18.2 mill. (gross) was invested, thereof financed with subsidies EUR 3.1 mill. (9M 2015: EUR 20.0 mill. thereof with subsidies EUR 1.7 mill.). Cash and cash equivalents as of 30 September 2016 amounted to EUR 40.5 mill. (31.12.2015: EUR 29.5 mill.). The equity ratio was 49.0 % (31.12.2015: 51.3 %). MEDICLIN employed an average of 6,604 employees, calculated on the basis of full-time staff, in the first nine months of 2016 (9M 2015: 6,500 full-time employees). Outlook The business performance in the first nine months of the 2016 financial year indicates that the sales target of 3.0 % growth announced for the Group will be exceeded. The Management Board anticipates sales growth in the range of approximately 4.5 %. Provided the post-acute segment continues to perform well, Group EBIT will be in line with the forecast range (guidance: Group EBIT between EUR 24 mill. and EUR 26 mill.). The interim report as of 30 September 2016 is available under www.mediclin.de in German and English. Key figures and yoy comparison for the Group and the segments

in million EUR                              9M 2016               9M 2015
Group
Group sales                                   435.2                 414.4
Raw materials and consumables                  80.7                  76.9
used
Staff costs                                   251.9                 240.4
Depreciation and amortisation                  14.1                  13.7
Other operating expenses                       76.2                  71.0
Group operating result                         17.8                  17.4
Total consolidated result                      12.5                  12.5
attributable to shareholders
Cash flow from operative                       20.7                  24.1
activities
Earnings per share in EUR                      0.26                  0.26
(un-/diluted)
Number of employees  (full                    6,604                 6,500
time staff on average)

Post-acute
Sales                                         262.9                 247.6
Segment result                                 18.8                  15.8
Acute
Sales                                         158.3                 153.6
Segment result                                  5.2                   7.2
Other activities and
reconciliation
Sales                                          14.0                  13.2
thereof business area nursing                  10.9                  10.4
care
Segment result                                 -6.2                  -5.6
(Due to arithmetical reasons, calculation differences may occur in the
table above)

About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510) MEDICLIN is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MEDICLIN has a total capacity of approximately 8,000 beds. MEDICLIN's facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post- acute treatment and medical rehabilitation. MEDICLIN has approximately 9,300 employees. MEDICLIN ─ a company of the Asklepios Group --------------------------------------------------------------------------- 10.11.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-326 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 519585 10.11.2016